Total Funding
49
41
Total FundingPost-IPO Debt raised
Growth Score
-7 pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
164675
Arecor is a leader in developing superior biopharmaceuticals through the application of its innovative formulation technology platform.
- Sarah Howell: Chief Executive OfficerPast Role: Union Chimique Belge, Director of Outsourced Manufacturing, Biologics
Jan Jezek: Chief Scientific OfficerPast Role: InSense, Principal Scientist
About the Company
Arecor is a leader in developing superior biopharmaceuticals through the application of its innovative formulation technology platform. Arecor is leveraging this platform to develop a portfolio of proprietary products enabling improved treatments for diabetes care via the innovative reformulation of approved proteins and peptides.
In addition to
its internal product portfolio, Arecor partners with leading pharmaceutical and biotech companies to deliver superior reformulations of their proprietary products, which would otherwise not be possible using conventional formulation science.
